7113 (Docusate 250 mg)
This pill with imprint "7113" is Red, Capsule-shape and has been identified as Docusate sodium 250 mg. It is supplied by Watson Pharmaceuticals.
Docusate is used in the treatment of constipation and belongs to the drug class laxatives. FDA has not classified the drug for risk during pregnancy. Docusate 250 mg is not a controlled substance under the Controlled Substance Act (CSA).
Docusate sodium
- Imprint:
- 7113
- Strength:
- 250 mg
- Color:
- Red
- Shape:
- Capsule-shape
- Availability:
- Rx and/or OTC
- Drug Class:
- Laxatives
- Pregnancy Category:
- N - Not classified
- CSA Schedule:
- Not a controlled drug
- Labeler / Supplier:
- Watson Pharmaceuticals
- Inactive Ingredients:
- FD&C Red No. 40
FD&C Yellow No. 6
gelatin
glycerin
polyethylene glycol
propylene glycol
water
sorbitol
Note: Inactive ingredients may vary.
More about docusate
- Side Effects
- During Pregnancy or Breastfeeding
- Dosage Information
- Drug Images
- Drug Interactions
- Support Group
- Pricing & Coupons
- En Español
- 11 Reviews – Add your own review/rating
- Drug class: laxatives
Consumer resources
Other brands: Colace, Dulcolax Stool Softener, Doc-Q-Lace, DOK, More... (22)
Professional resources
Related treatment guides
Disclaimer:
Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Copyright 2017 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.
